Home NDC 76466-011-07 Vagi-Cure Advanced Sensitive Medicated
Product NDC 76466-011
Requested package NDC 76466-011-07
11-digit product format 764660011
Labeler code 76466
Product ID 76466-011_d8c30919-0dee-4c4e-e053-2995a90a0dab
Type HUMAN OTC DRUG
Nonproprietary name BENZOCAINE, BENZALKONIUM CHLORIDE
Dosage form CREAM
Route TOPICAL
Labeler SCI International, Inc. DBA Continental Pharmaceuticals
Application part348
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2016-06-30
Marketing end 0000-00-00
Substance BENZALKONIUM CHLORIDE; BENZOCAINE
Active strength 0 g/100g; g/100g
Pharmacologic classes Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2021-12-27 23:28 UTC · source 2021-12-27 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 9bebd1f3094a…5416666fcb17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 76466-011-07 Vagi-Cure Advanced Sensitive Medicated 21 g in 1 TUBE CREAM 21 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 76466-011 VAGI-CURE ADVANCED SENSITIVE MEDICATED (BENZOCAINE, BENZALKONIUM CHLORIDE) CREAM [SCI INTERNATIONAL, INC. DBA CONTINENTAL PHARMACEUTICALS] 2 Legacy NDC, 1 package rows 20220225_624a948a-8db6-4834-aead-ed8dfbe97e03.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 76466-011-07 76466001107 21 g in 1 TUBE (76466-011-07) 21 g 2016-06-30 0000-00-00 No No Current